Last reviewed: July 8, 2026
Last updated: July 8, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide works as a once-weekly injection that suppresses appetite and improves blood sugar control by mimicking glucagon-like peptide-1 (GLP-1), a hormone your gut naturally produces. Understanding the correct dosing frequency and titration schedule is essential for safe, effective results. PlexusDx compounds pharmaceutical-grade semaglutide from licensed 503A pharmacies, delivering personalized treatment plans that match your body's response.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
Semaglutide Injection Frequency: Weekly Dosing Explained
Semaglutide is taken exactly once per week, every seven days, making it one of the most convenient weight-loss medications available. You inject the same dose on the same day each week—for example, every Monday morning—to maintain steady hormone levels in your bloodstream. This consistent weekly schedule allows your body to adapt gradually and reduces the likelihood of sudden side effects or breakthrough hunger episodes.
The medication reaches peak concentration about 24 to 72 hours after injection, which is why weekly dosing provides continuous appetite suppression throughout the entire seven-day cycle. Missing a dose by a day or two is generally tolerable, but PlexusDx recommends setting phone reminders to keep your weekly injection routine consistent. Consistency matters because semaglutide's weight-loss benefits depend on maintaining stable drug levels week to week.
Understanding the 16-Week Titration Protocol for Semaglutide
Rather than starting at full therapeutic dose, semaglutide follows a gradual 16-week titration schedule that begins at 0.25 mg and increases every week until reaching your target maintenance dose, typically between 1.0 and 2.4 mg per week. This slow escalation strategy dramatically reduces nausea, vomiting, and gastrointestinal upset during the first month of treatment. Clinical trials show that patients who follow this step-wise increase have better medication tolerability and higher rates of staying on therapy long-term.
Week one through four introduces 0.25 mg doses, allowing your GLP-1 receptors to sensitize without overwhelming your system. Weeks five through eight increase to 0.5 mg, then 0.75 mg, and finally 1.0 mg by the end of week twelve. Your PlexusDx provider may adjust this timeline based on your individual response, side effect profile, and weight-loss progress, but the principle remains: slow, steady dose increases win the race against hunger and excess weight.
Maintenance Dosing: Finding Your Effective Weekly Dose
Once you complete the titration phase, most patients reach a maintenance dose between 1.0 and 2.4 mg weekly, taken on the same day each week indefinitely as long as treatment continues. Your specific maintenance dose depends on how well you respond to the medication, your target weight-loss goal, and any side effects you experience at higher doses. PlexusDx providers work with you to identify the lowest effective dose that produces meaningful appetite suppression without intolerable gastrointestinal symptoms.
Some patients plateau in weight loss at 1.0 or 1.5 mg weekly and prefer to stay there rather than climb toward 2.4 mg, while others need the higher dose to achieve their goals. The beauty of semaglutide is its flexibility: your dose may need to go up over time as your body adapts, but your price won't change with PlexusDx. Starting at just $189 per month, compounded semaglutide injections remain flat across all dose levels, making higher doses accessible without financial penalty.
How Genetic Factors Shape Your Semaglutide Response and Dosing Needs
The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761), and GIPR (rs1800437) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
Understanding your genetic predisposition to GLP-1 responsiveness helps PlexusDx tailor your dosing schedule from day one rather than relying on trial-and-error adjustments. The test costs just $99 as an add-on after your first month of treatment and is worth it if you want to optimize your weekly dose and avoid wasting months on suboptimal therapy. By combining genetic insights with clinical monitoring, PlexusDx helps you reach your target dose faster and with fewer frustrating adjustments.
What Happens If You Miss a Semaglutide Injection or Need to Adjust Your Schedule
If you miss your weekly semaglutide injection, take it as soon as you remember unless it is within two days of your next scheduled dose—in that case, skip the missed dose and resume your normal weekly schedule. Missing one injection will not erase your progress, but it may trigger temporary hunger or appetite rebound as the medication level drops in your bloodstream. PlexusDx recommends using pill organizers, phone alarms, or calendar reminders to prevent missed doses, which are the number one reason patients experience weight regain during treatment.
If you need to temporarily adjust your injection day due to travel or scheduling conflicts, PlexusDx providers can help you shift your weekly schedule without affecting dosing safety or efficacy. The key is maintaining a seven-day interval between injections; taking two doses within a short timeframe or stretching beyond eight days creates inconsistent hormone levels and reduces appetite suppression. Always communicate schedule changes with your PlexusDx care team to ensure your dosing remains optimized for continuous weight loss.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How many times per week do you take semaglutide?
Semaglutide is taken exactly once per week via subcutaneous injection, always on the same day each week for best results. You'll inject it into your thigh, abdomen, or upper arm and maintain this weekly routine throughout your entire treatment period with PlexusDx.
How long does it take to see weight loss results with semaglutide injections?
Most patients notice appetite suppression and early weight loss within two to three weeks of starting semaglutide, with more significant results appearing after 8 to 12 weeks as you reach higher maintenance doses. Clinical trials show average weight loss of 5% to 15% of body weight within six months, with continued losses up to one year depending on your dose, genetics, and lifestyle adherence.
Can PlexusDx help me find the right semaglutide dose without guessing?
No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
What are the most common side effects during semaglutide titration?
Nausea, vomiting, constipation, and mild abdominal discomfort occur in about 20% to 40% of patients during the first month, but the gradual 16-week titration protocol used by PlexusDx significantly reduces severity. Side effects typically peak during weeks one through four and improve as your body adjusts; eating smaller, lower-fat meals also helps minimize gastrointestinal upset.
How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?
No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GLP1R (rs6923761), and GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Will One Shot of Ozempic Do Anything?
Navigating Zepbound Doses: What Does Increasing the Dose of Zepbound Do?